Researchers Identify Cellular Change That Could Help Stop Acute Myeloid Leukemia

Researchers at the Bellvitge Biomedical Research Institute (IDIBELL), in collaboration with the Catalan Institute of Oncology (ICO), have identified an epigenetic modification that could become a new research target for acute myeloid leukemia (AML). The study found that increasing histone H3 methylation at lysine 9 (H3K9) may help combat this aggressive blood cancer. This discovery opens new therapeutic possibilities for AML patients, a condition that affects thousands of Puerto Ricans annually. Understanding these cellular mechanisms could lead to more effective treatments and improved survival rates.
Originally published on
DiarioSalud.do
By Diario Salud Redacción
Read full article(opens in new tab)Fetched: September 21, 2026 at 10:01 AM



